- Exchange: OTC US
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Life Science Equipment
PURE Bioscience Inc
+ Add to WatchlistPURE:US
0.3899 USD 0.0179 4.39%As of 17:20:00 ET on 06/19/2013.
Snapshot for PURE Bioscience Inc (PURE)
| Open: | 0.3300 | Day's Range: | 0.3300 - 0.4000 | Volume: | 34,532 |
|---|---|---|---|---|---|
| Previous Close: | 0.4078 | 52wk Range: | 0.2203 - 3.9920 | 1-Yr Rtn: | -85.67% |
Key Statistics for PURE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(07/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.9892 |
| Est. EPS (07/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 4.83 |
| Shares Outstanding (M) | 12.39 |
| 30 Day Average Volume | 72,766 |
| Price/Book (mrq) | 5.2659 |
| Price/Sale (ttm) | 4.8924 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 10/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PURE
Company Profile & Key Executives for PURE
PURE Bioscience, Inc. develops and markets technology-based products in the bioscience and water treatment sectors to provide non-toxic solutions to global health challenges. The Company's technologies include its silver dihydrogen citrate-based anti-microbials and boric acid-based pesticides.
| Dave J PfanzelterChairman | Michael L KrallPresident/CEO/CFO/Founder |
| Donna M SingerExecutive Vice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PURE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page